Home

Barry Canton

CIK 1882756 · last filed 2026-07-30

Barry Canton is a corporate insider who has filed 133 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for DNA, was dated Jul 30, 2026. Across all open-market trades the lifetime net is −$60.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.57M

Companies

2

Total Filings

133

Lifetime Open-Market Net

-$60.74M

Filer Profile

Reported Address
C/O GINKGO BIOWORKS, INC.
27 DRYDOCK AVENUE, 8TH FLOOR
BOSTON, MA 02210
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DNA 10%+ Owner 801,261 $6.95 $5.57M -$977.6K 3 2026-07-30
Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted 10%+ Owner 24,749,098 $0.01 $155.9K -$59.76M 91 2024-04-29

Recent Filings

133 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-30 DNA Grant (A) — $0 EDGAR
2026-04-13 DNA Mixed +127,059 -$802.5K EDGAR
2026-04-10 DNA Mixed +29,205 -$175.1K EDGAR
2026-04-09 DNA Notice (144) −13,116 -$83.9K EDGAR
2026-04-08 DNA Notice (144) −13,155 -$91.2K EDGAR
2024-04-29 Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted Grant (A) — $0 EDGAR
2023-12-22 Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted Sell (S) −75,300 -$133.0K EDGAR
2023-12-21 DNA Notice (144) −37,650 -$66.3K EDGAR
2023-12-15 Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted Sell (S) −75,300 -$111.8K EDGAR
2023-12-14 DNA Notice (144) −37,650 -$55.7K EDGAR
Showing 1–10 of 133
Page 1 of 14
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.